高级检索
    乔贵宾, 程华. KRAS基因突变与肺腺癌对Gefitinib和Erlotinib原发耐药的关系[J]. 循证医学, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007
    引用本文: 乔贵宾, 程华. KRAS基因突变与肺腺癌对Gefitinib和Erlotinib原发耐药的关系[J]. 循证医学, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007
    shu
    QIAO Gui-bin, CHENG Hua. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007
    Citation: QIAO Gui-bin, CHENG Hua. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007
    shu

    KRAS基因突变与肺腺癌对Gefitinib和Erlotinib原发耐药的关系

    KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回